StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

VivoSim Labs's operating income for the twelve months ending Jun 30, 2026 was -$11.33M. For fiscal 2026 it was -$11.49M. The highest annual figure on record is -$1.18M in fiscal 2010.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$11.49M–
FY2025Mar 31, 2025-$12.62M–
FY2024Mar 31, 2024-$15.09M–
FY2023Mar 31, 2023-$17.73M–
FY2022Mar 31, 2022-$11.48M–
FY2021Mar 31, 2021-$16.83M–
FY2020Mar 31, 2020-$21.48M–
FY2019Mar 31, 2019-$27.27M–
FY2018Mar 31, 2018-$35.27M–
FY2017Mar 31, 2017-$38.58M–
FY2016Mar 31, 2016-$38.64M–
FY2015Mar 31, 2015-$30.30M–
FY2012Dec 31, 2012-$9.32M–
FY2011Dec 31, 2011-$2.31M–
FY2010Dec 31, 2010-$1.18M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$2.76M–
Q4 FY2026CQ1 2026Mar 31, 2026-$3.19M–
Q3 FY2026CQ4 2025Dec 31, 2025-$2.75M–
Q2 FY2026CQ3 2025Sep 30, 2025-$2.64M–
Q1 FY2026CQ2 2025Jun 30, 2025-$2.92M–
Q4 FY2025CQ1 2025Mar 31, 2025-$3.15M–
Q3 FY2025CQ4 2024Dec 31, 2024-$3.47M–
Q2 FY2025CQ3 2024Sep 30, 2024-$2.61M–
Q1 FY2025CQ2 2024Jun 30, 2024-$3.39M–
Q4 FY2024CQ1 2024Mar 31, 2024-$3.10M–
Q3 FY2024CQ4 2023Dec 31, 2023-$3.68M–
Q2 FY2024CQ3 2023Sep 30, 2023-$4.12M–
Q1 FY2024CQ2 2023Jun 30, 2023-$4.20M–
Q4 FY2023CQ1 2023Mar 31, 2023-$7.78M–
Q3 FY2023CQ4 2022Dec 31, 2022-$3.36M–
Q2 FY2023CQ3 2022Sep 30, 2022-$3.35M–
Q1 FY2023CQ2 2022Jun 30, 2022-$3.24M–
Q4 FY2022CQ1 2022Mar 31, 2022-$1.91M–
Q3 FY2022CQ4 2021Dec 31, 2021-$3.50M–
Q2 FY2022CQ3 2021Sep 30, 2021-$3.51M–
Q1 FY2022CQ2 2021Jun 30, 2021-$2.56M–
Q4 FY2021CQ1 2021Mar 31, 2021-$2.60M–
Q3 FY2021CQ4 2020Dec 31, 2020-$2.49M–
Q2 FY2021CQ3 2020Sep 30, 2020-$8.95M–
Q1 FY2021CQ2 2020Jun 30, 2020-$2.79M–
Q4 FY2020CQ1 2020Mar 31, 2020-$2.89M–
Q3 FY2020CQ4 2019Dec 31, 2019-$5.23M–
Q2 FY2020CQ3 2019Sep 30, 2019-$6.83M–
Q1 FY2020CQ2 2019Jun 30, 2019-$6.52M–
Q4 FY2019CQ1 2019Mar 31, 2019-$7.16M–
Q3 FY2019CQ4 2018Dec 31, 2018-$6.53M–
Q2 FY2019CQ3 2018Sep 30, 2018-$6.01M–
Q1 FY2019CQ2 2018Jun 30, 2018-$7.58M–
Q4 FY2018CQ1 2018Mar 31, 2018-$7.58M–
Q3 FY2018CQ4 2017Dec 31, 2017-$7.91M–
Q2 FY2018CQ3 2017Sep 30, 2017-$9.58M–
Q1 FY2018CQ2 2017Jun 30, 2017-$10.20M–
Q4 FY2017CQ1 2017Mar 31, 2017-$10.69M–
Q3 FY2017CQ4 2016Dec 31, 2016-$9.63M–
Q2 FY2017CQ3 2016Sep 30, 2016-$9.48M–

More VivoSim Labs figures

See a number that looks wrong?